Unisense

The US Food and Drug Administration has granted 510(k) clearance for Unisense FertiliTech’s Compare & Select feature in the EmbryoViewer software, an accessory in the EmbryoScope time-lapse incubator.

The company said that evaluation criteria already implemented for embryo selection in a specific clinic can be converted into a model in the Compare & Select feature of the EmbryoViewer software.

The EmbryoScope time-lapse incubator assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals who want to be a parent.

Unisense FertiliTech chief commercial officer Vagn Rasmussen said: "We’re excited to receive the FDA 510(k) clearance for the EmbryoViewer software, and believe this will aid IVF professionals in the selection of embryos that are likely to produce a live birth.

"The newly released software provides embryologists a new tool to design a set of models that can be used for scoring embryos and provide a stronger and more informed basis to make a better decision."

"We have developed a software that allows IVF professionals to observe embryo development events which they may have previously missed.

"The newly released software provides embryologists a new tool to design a set of models that can be used for scoring embryos and provide a stronger and more informed basis to make a better decision."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company has obtained FDA 510(k) and CE Mark approvals for the time-lapse system as a Class II medical device. It can be employed for clinical use in ART procedures.

A recent study has showed improvement in clinical outcomes when using a customised embryo evaluation model, which was developed and implemented using the Compare & Select feature of the EmbryoViewer software.


Image: EmbryoScope time-lapse system. Photo: courtesy of PR Newswire/ Unisense FertiliTech A/S.